Effect of antibiotic prophylaxis on the risk of surgical site infection in orthotopic liver transplant

Angel Asensio, Antonio Ramos, Valentin Cuervas‐Mons, Elisa Cordero, Victor Sánchez‐Turrión, Marino Blanes, Carlos Cervera, Joan Gavalda, Jose M. Aguado, Julian Torre‐Cisneros – 28 May 2008 – Surgical site infections are common bacterial infections in orthotopic liver transplantation. The purpose of this study was to determine the incidence, timing, location, and risk factors, specifically antibiotic prophylaxis, for surgical site infections.

Liver transplantation for subacute hepatocellular failure due to massive steatohepatitis after bariatric surgery

Luiz Augusto Carneiro D'Albuquerque, Adriano Miziara Gonzalez, Raul Carlos Wahle, Evandro de Oliveira Souza, Jorge Marcelo Padilla Mancero, Adávio de Oliveira e Silva – 28 May 2008 – New therapeutic options for obesity include restrictive bowel surgery and surgery that promotes malabsorption, such as the Fobi‐Capella (gastric bypass) and Scopinaro (biliopancreatic diversion) techniques. Complications associated with these procedures, such as hepatocellular failure, have been observed with increasing frequency.

The prevalence of a heparin‐like effect shown on the thromboelastograph in patients undergoing liver transplantation

Seema Agarwal, Marco Senzolo, Clare Melikian, Andrew Burroughs, Susan V. Mallett – 28 May 2008 – It has been known for several decades that thromboelastographic analysis of the blood of patients undergoing liver transplantation may show a heparin‐like effect (HLE) at the time of reperfusion. However, the prevalence of HLE and the origin of these heparin‐like substances remain largely unstudied.

Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virus

M. Isabel Fiel, Kaushik Agarwal, Carmen Stanca, Nassim Elhajj, Nikolas Kontorinis, Swan N. Thung, Thomas D. Schiano – 28 May 2008 – De novo autoimmune hepatitis has been described in both pediatric and adult liver transplantation (LT) recipients. Studies of small numbers of patients have proposed it to be an alloimmune hepatitis or form of chronic rejection. We have recently noted an increasing number of patients with post‐LT recurrent hepatitis C virus (HCV) developing this, with an apparent negative impact on outcome and survival.

Subscribe to